MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. MapLight Therapeutics (NAS: MPLT) is based in Burlington, MA and was founded in 2018. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $704 million (Oct 2025). It has raised $919 million.
Last price · $/share
—
Implied valuation
$704.3M
Total raised
$919.4M
Last round
—
Cap table — not yet on record
MapLight Therapeutics (NAS: MPLT)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
